http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101969121-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 |
| filingDate | 2014-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101969121-B1 |
| titleOfInvention | Cysteine-engineered antibody |
| abstract | The present invention relates to a carpe constant region of a light chain in which the amino acid of any one of glutamic acid at the 15th position, glutamine at the 16th position, leucine at the 17th position or glutamine at the 47th position in the amino acid sequence of SEQ ID NO: , Wherein the antibody of the present invention is a human immunoglobulin antibody, wherein the specific amino acid in the kappa constant region of the light chain is replaced by a cysteine to form a magnetic bead, plate, or antibody for immunodiagnosis through the free thiol of cysteine The site specific binding to the fluorescent protein can improve the sensitivity of the immunoassay and can be useful for the qualitative and quantitative analysis of the target protein without the background signal. |
| priorityDate | 2014-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 1163.